PRICE T ROWE ASSOCIATES INC /MD/ - TAYSHA GENE THERAPIES INC ownership

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 106 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2024. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of TAYSHA GENE THERAPIES INC
ValueSharesWeighting
Q2 2024$2,861
-9.3%
1,276,578
+16.1%
0.00%
Q1 2024$3,156
+45.2%
1,099,329
-10.4%
0.00%
Q4 2023$2,173
-44.9%
1,227,333
-1.6%
0.00%
-100.0%
Q3 2023$3,9431,247,4710.00%
Other shareholders
TAYSHA GENE THERAPIES INC shareholders Q2 2024
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,330,937$5,221,2994.40%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,700,000$8,288,0001.68%
Octagon Capital Advisors LP 4,572,222$10,241,7771.61%
VR Adviser, LLC 9,000,000$20,160,0001.28%
Ghost Tree Capital, LLC 1,250,000$2,800,0000.88%
RTW INVESTMENTS, LP 18,800,299$42,112,6700.65%
Diametric Capital, LP 512,361$1,147,6880.62%
Quantum Private Wealth, LLC 730,520$1,636,3650.58%
Avoro Capital Advisors LLC 18,650,000$41,776,0000.56%
Sands Capital Ventures, LLC 724,873$1,623,7160.54%
View complete list of TAYSHA GENE THERAPIES INC shareholders